Trials / Completed
CompletedNCT04158167
Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study
Neurobiological Effects of Oxytocin on Metacognitive Deficits in Schizophrenia: A Pharmacological - Imaging Genetics Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- National Institute of Mental Health and Neuro Sciences, India · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To investigate whether 24IU oxytocin can result in changes in functional brain connectivity in patients with schizophrenia and healthy individuals using functional magnetic resonance imaging (fMRI). The study will also examine the effect of oxytocin receptor gene polymorphism on the functional connectivity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxytocin | 24 International units of oxytocin or palcebo will be given intranasally. The order of administration will be counterbalanced |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2018-12-30
- Completion
- 2018-12-30
- First posted
- 2019-11-08
- Last updated
- 2019-11-08
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04158167. Inclusion in this directory is not an endorsement.